眼科

• 述评 • 上一篇    下一篇

未来青光眼手术路在何方?

张秀兰  李飞   

  1. 510060广州,中山大学中山眼科中心
  • 收稿日期:2017-10-29 出版日期:2018-01-25 发布日期:2018-01-26
  • 通讯作者: 张秀兰,Email:xiulan_z@qq.com
  • 基金资助:

    国家自然科学基金(81670847)

Glaucoma surgery: what we need to know now for the future?

 ZHANG Xiu-lan, LI Fei   

  1. Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou 510060, China
  • Received:2017-10-29 Online:2018-01-25 Published:2018-01-26
  • Contact: ZHANG Xiu-lan, Email: xiulan_z@qq.com

摘要:

降低眼压迄今仍是目前临床上被证明唯一有效的青光眼治疗方式。手术治疗降低眼压是应对中晚期青光眼的最有效手段。现代青光眼手术技术不断创新,但仍存在两大主要难关。首先,滤过性手术存在术后瘢痕化及潜在并发症等诸多弊端,多种新型微创青光眼手术(micro-invasive glaucoma surgery,MIGS)的出现一定程度上避免了以上问题;其次,尽管目前青光眼手术技术日新月异,但对于大多数难治性青光眼病例,利用现有手术技术仍难以达到理想的治疗效果。因此,青光眼手术技术仍有极大的发展空间。未来青光眼手术将形成以MIGS为主流的手术体系,并不断研发新技术,包括人工智能辅助下的抗青光眼手术新模式,逐步征服各种极端复杂的难治性青光眼。(眼科, 2018, 27: 1-3)

关键词: 青光眼/外科学, 微创青光眼手术

Abstract:

 Glaucoma is currently the second leading reason for blindness in the world. In clinical practice, intraocular pressure (IOP) lowering is the only effective way proven to be effective in controlling disease progression. With development of modern cataract surgery and vitreoretinal surgery, surgical techniques of glaucoma have changed a lot. However, there are 2 major challenges. First, traditional filtering surgeries still need improvement in controlling post-surgical scarring and complications. Invention of micro-invasive glaucoma surgery (MIGS) resolved these problems to some extent. Second, for intractable cases, current surgical techniques cannot achieve satisfactory therapeutic effect for all cases. Therefore, there is still a long way for surgical techniques of glaucoma to go. We can expect that MIGS will become the mainstream and refractory glaucoma will be conquered in the future. (Ophthalmol CHN, 2018, 27: 1-3)

Key words: glaucoma/surgery, micro-invasive glaucoma surgery